Showing results (31-40 of 237) with videos related to

Sort By:
Pageof 24
Annals of Hematology|February 7, 2023
Amsacrine-based induction therapy in AML patients with cardiac comorbidities: a retrospective single-center analysisDavid Kuron, Alexander Pohlmann, Linus Angenendt, et al.
Cancer Research|October 31, 2019
Adhesion of T Cells to Endothelial Cells Facilitates Blinatumomab-Associated Neurologic Adverse EventsMatthias Klinger, Gerhard Zugmaier, Virginie Nägele, et al.
Annals of Hematology|July 10, 2023
Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML)Alexander Pohlmann, Eva Bentgens, Christoph Schülke, et al.
Cancer|August 2, 2024
Inotuzumab ozogamicin in adult acute lymphoblastic leukemia: Development, current status, and future directionsHagop M Kantarjian, Nicolas Boissel, Cristina Papayannidis, et al.
Bone Marrow Transplantation|May 3, 2024
Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patientsPhilipp Berning, Lina Kolloch, Christian Reicherts, et al.
Blood Cells, Molecules & Diseases|September 18, 2007
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an updateWolfgang A Bethge, Christoph Faul, Martin Bornhäuser, et al.
Cancer Medicine|August 23, 2019
Burden of hospitalization in acute lymphoblastic leukemia patients treated with Inotuzumab Ozogamicin versus standard chemotherapy treatmentDavid I Marks, Ilse van Oostrum, Sabrina Mueller, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 11, 2020
Blinatumomab or Inotuzumab Ozogamicin as Bridge to Allogeneic Stem Cell Transplantation for Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia: A Retrospective Single-Center AnalysisPatrick Stelmach, Klaus Wethmar, Christoph Groth, et al.
Transplantation and Cellular Therapy|October 13, 2025
Treosulfan-Based Conditioning Ameliorates the Impact of Pretransplantation Measurable Residual Disease-Positivity in Acute Myeloid Leukemia Patients Allografted in RemissionJacob Pyka, Judith Metzdorf, Christian Reicherts, et al.
Transplantation and Cellular Therapy|June 26, 2025
High-Dose Melphalan Followed by Busulfan and Fludarabine Conditioning Prior to Allogeneic Stem Cell Transplantation in Elderly Patients with Active Acute Myeloid Leukemia-A Retrospective Single-Center StudyJulian Ronnacker, Marc-Andre Urbahn, Christian Reicherts, et al.
Pageof 24